Ahit, Zia Dexzie P.

HRN: 21-83-18  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/06/2025
OXACILLIN 500MG (VIAL)
05/06/2025
05/12/2025
IV
400mg
Q6
Impetigo
Waiting Final Action 
05/06/2025
MUPIROCIN 2%, 15G (TUBE)
05/06/2025
05/12/2025
TOPICAL
15g
TID
Impetigo
Waiting Final Action 
05/07/2025
CEFUROXIME 750MG (VIAL)
05/07/2025
05/13/2025
IV
540mg
Q8h
UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: